Floatz logo

47 assets in Squamous Cell Lung Carcinoma

Therapeutic assets addressing Squamous Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cis-Diamminedichloroplatinum Ii
Squamous Cell Lung Carcinoma
Qilu Hospital of Shandong UniversityP4BBB (78)
Carboplatin
Squamous Cell Lung Carcinoma
zhang yiP3BBB (76)
Docetaxel
Squamous Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P3BBB (72)
Cyclophosphamide
Squamous Cell Lung Carcinoma
UNC Lineberger Comprehensive Cancer CenterP3BB (70)
Etoposide
Squamous Cell Lung Carcinoma
Barbara Ann Karmanos Cancer InstituteP3BB (68)
Veliparib
Squamous Cell Lung Carcinoma
AbbVieP3BB (66)
Pembrolizumab
Squamous Cell Lung Carcinoma
UNC Lineberger Comprehensive Cancer CenterP2BB (65)
Ivonescimab
Squamous Cell Lung Carcinoma
Everest Medicines (Beijing) Co., Ltd.P2B (60)
Si-B001
Squamous Cell Lung Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3B (60)
Fludarabine
Squamous Cell Lung Carcinoma
Intima Bioscience, Inc.P2B (59)
hb1801
Squamous Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P2/3B (57)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Monoclonal Jmt101 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Jmt101 ?-Chain, Dimer
Squamous Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P2/3B (57)
Pegfilgrastim
Squamous Cell Lung Carcinoma
Wake Forest University Health SciencesP2B (57)
Durvalumab
Squamous Cell Lung Carcinoma
University of British ColumbiaP2CCC (53)
Envafolimab
Squamous Cell Lung Carcinoma
Qilu Hospital of Shandong UniversityP2CCC (53)
Intismeran Autogene
Squamous Cell Lung Carcinoma
Merck Sharp & Dohme LLCP2CCC (53)
Nivestim
Squamous Cell Lung Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Petosemtamab
Squamous Cell Lung Carcinoma
Merus B.V.P2CCC (53)
Pimurutamab
Squamous Cell Lung Carcinoma
Shanghai Henlius BiotechP2CCC (53)
Serplulimab
Squamous Cell Lung Carcinoma
Shanghai Henlius BiotechP2CCC (53)
Tislelizumab
Squamous Cell Lung Carcinoma
SOLTI Breast Cancer Research GroupP2CCC (53)
Spartalizumab
Squamous Cell Lung Carcinoma
SOLTI Breast Cancer Research GroupP2CCC (50)
Ale.P02
Squamous Cell Lung Carcinoma
Alentis Therapeutics AGP1/2CCC (48)
Ale.P03
Squamous Cell Lung Carcinoma
Alentis Therapeutics AGP1/2CCC (48)
Fulvestrant
Squamous Cell Lung Carcinoma
Terremoto Biosciences Inc.P1/2CCC (48)
gpc3-car-t cells
Squamous Cell Lung Carcinoma
Sotio Biotech Inc.P1/2CCC (48)
Puxitatug Samrotecan
Squamous Cell Lung Carcinoma
AstraZenecaP1/2CCC (48)
Rilvegostomig
Squamous Cell Lung Carcinoma
AstraZenecaP1/2CCC (48)
Ter-2013
Squamous Cell Lung Carcinoma
Terremoto Biosciences Inc.P1/2CCC (48)
Valemetostat
Squamous Cell Lung Carcinoma
National Cancer Institute (NCI)P1/2CCC (48)
Vls-1488
Squamous Cell Lung Carcinoma
Volastra Therapeutics, Inc.P1/2CCC (48)
Cish Inactivated Tumor Infiltrating Lymphocytes
Squamous Cell Lung Carcinoma
Intima Bioscience, Inc.P1/2CC (47)
Neoantigen Specific Tcr-T Cell Drug Product
Squamous Cell Lung Carcinoma
Alaunos TherapeuticsP1/2CC (47)
Palacaparib
Squamous Cell Lung Carcinoma
AstraZenecaP1/2CC (47)
Saruparib
Squamous Cell Lung Carcinoma
AstraZenecaP1/2CC (47)
Torvutatug Samrotecan
Squamous Cell Lung Carcinoma
AstraZenecaP1/2CC (47)
tt125-802
Squamous Cell Lung Carcinoma
TOLREMO therapeutics AGP1CC (46)
evm14
Squamous Cell Lung Carcinoma
Everest Medicines (Beijing) Co., Ltd.P1CC (43)
Evolve104
Squamous Cell Lung Carcinoma
EvolveImmune United, IncP1CC (43)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Clone Bca101 ?1-Chain), Disulfide With Human-Mus Musculus Clone Bca101 ?-Chain Fusion Protein With Peptide Linker (Ggggs)3 Fusion Protein With 23-159-Transforming Growth Factor ? Receptor Tgfbr2 (Human), Dimer
Squamous Cell Lung Carcinoma
Bicara TherapeuticsP1CC (43)
jmt106
Squamous Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P1CC (43)
Panda-Vac
Squamous Cell Lung Carcinoma
UNC Lineberger Comprehensive Cancer CenterP1CC (43)
Rph-075
Squamous Cell Lung Carcinoma
R-PharmP1CC (43)
zw251
Squamous Cell Lung Carcinoma
Zymeworks BC Inc.P1CC (43)
inn805
Squamous Cell Lung Carcinoma
FindCure Biosciences (ZhongShan) Co., Ltd.Early P1C (39)
Microlyvaq™
Squamous Cell Lung Carcinoma
Biogenea Pharmaceuticals Ltd.Early P1C (39)
Sapanisertib
Squamous Cell Lung Carcinoma
Faeth TherapeuticsP2NR ()